December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
Market insights predict, the clinical trial supplies industry is expected to grow from USD 4.9 billion in 2024 to USD 11.4 billion by 2034, driven by a CAGR of 8.87%.The increasing number of clinical trials and the growing need for novel therapeutics bolster the market. The availability of favorable infrastructure and the presence of key players ...
November 01, 2025
Based on market forecasts, the disposable hospital supplies sector will expand from USD 26.69 billion in 2024 to USD 62.5 billion by 2034, experiencing a CAGR of 9.01%. A rise in focus on infection control and home healthcare is driving the global market. North America led the market due to its growing healthcare expenditure....
November 01, 2025
According to market projections, the global gene overexpression cell line construction market, valued at USD 788.63 million in 2024, is anticipated to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% over the next decade. The versatility of an overexpression research tool makes it popular among wild-type and mutant research. North Ame...
November 01, 2025
Market insights predict the global U.S. medical alert systems industry will increase from USD 2.59 billion in 2024 to USD 7.76 billion by 2034, achieving a CAGR of 11.6%. The U.S. medical alert systems market is investment by the government....
November 01, 2025
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 4.90 billion in 2024 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs work with cell and gene therapies targeting a wide array of diseases, cancer, rare and inherited geneti...
November 01, 2025
Projections indicate that, the global cell and gene therapy cold chain logistics market will increase from USD 1.89 billion in 2024 to USD 8.06 billion by 2034, experiencing a CAGR of 15.64% over the next 10 years. The cell and gene therapy cold chain logistics market is expanding due to advancing cold chain technologies as well as increasing cell ...
November 01, 2025
Based on market forecasts, the global cell and gene therapy manufacturing QC market, projected at USD 2.66 billion in 2024, is expected to reach USD 12.35 billion by 2034, growing at a CAGR of 16.89% over the forecast period. The growing demand for cell and gene therapy and stringent regulatory policies drive the global market. North America domina...
November 01, 2025
Based on market forecasts, the global cell and gene supply chain solutions market, projected at USD 3.54 billion in 2024, is expected to reach USD 14.95 billion by 2034, growing at a CAGR of 15.54% over the forecast period. The cell and gene supply chain solutions market is growing due to the rising need for personalized therapies. North America&rs...
November 01, 2025
The rising prevalence of chronic disorders and advancements in genomic technologies bolster market growth. North America led the global market owing to the growing demand for biologics and the presence of key players....
November 01, 2025
Projections indicate that, digital health insurance industry is projected to rise from USD 3.57 trillion in 2024 to USD 11.11 trillion by 2034, reflecting a CAGR of 12.05% over the next decade. The global customer-driven demand for convenience, personalization, and technological innovation supports the expansive reach of digital health insurance se...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com